首页> 美国卫生研究院文献>Diabetes Metabolism Journal >Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database

【2h】

Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database

机译：使用韩国健康保险理赔数据库使用新处方的Depteptidyl Peptidase-4抑制剂和吡格列酮增加了因心力衰竭住院的风险

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundWe assessed the association of dipeptidyl peptidase 4 inhibitors (DPP4i) with hospitalization for heart failure (HF) using the Korean Health Insurance claims database.

机译：背景我们使用韩国健康保险理赔数据库评估了二肽基肽酶4抑制剂（DPP4i）与心衰（HF）住院的相关性。

著录项

期刊名称 Diabetes Metabolism Journal
作者
Sunghwan Suh; Gi Hyeon Seo; Chang Hee Jung; Mee-Kyoung Kim; Sang-Man Jin; You-Cheol Hwang; Byung-Wan Lee; Jae Hyeon Kim;
展开▼
作者单位

展开▼
年(卷),期 2015(39),3
年度 2015
页码 247–252
总页数 6
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Dipeptidyl-peptidase IV inhibitors Heart failure Pioglitazone;

机译：二肽基肽酶IV抑制剂;心力衰竭;吡格列酮;

相似文献

外文文献
中文文献
专利

1. Dipeptidyl Peptidase-4 Inhibitor Reduces the Risk of Developing Hypertrophic Scars and Keloids following Median Sternotomy in Diabetic Patients: A Nationwide Retrospective Cohort Study Using the National Database of Health Insurance Claims of Japan [J] . Plastic and reconstructive surgery . 2020,第1期

机译：二肽基肽酶-4抑制剂降低了糖尿病患者中位数胸骨切开术后培养肥厚疤痕和瘢痕疙瘩的风险：使用日本的国家健康保险索赔数据库的全国回顾队列研究
2. No increased risk of hospitalization for heart failure for patients treated with dipeptidyl peptidase-4 inhibitors in Taiwan [J] . Chang Chia-Hsuin, Chang Yi-Cheng, Lin Jou-Wei, International Journal of Cardiology . 2016,第Null期

机译：台湾使用二肽基肽酶-4抑制剂治疗的患者因心力衰竭而住院的风险没有增加
3. No increased risk of hospitalization for heart failure for patients treated with dipeptidyl peptidase-4 inhibitors in Taiwan [J] . Chang Chia-Hsuin, Chang Yi-Cheng, Lin Jou-Wei, International Journal of Cardiology . 2016,第Null期

机译：对于台湾二肽肽肽酶-4抑制剂治疗的患者没有增加心力衰竭的风险
4. Predicting number of hospitalization days based on health insurance claims data using bagged regression trees [C] . Xie Yang, Schreier Gunter, Chang David C.W., Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2014

机译：使用袋装回归树根据健康保险理赔数据预测住院天数
5. The effect of beta-blocker therapy, ACE inhibitor therapy, and digoxin therapy on the risk of hospitalization and resource utilization among patients with congestive heart failure enrolled in a managed care organization. [D] . Abarca, Jacob. 2001

机译：在管理性医疗机构中，充血性心力衰竭患者的β受体阻滞剂治疗，ACEI抑制剂治疗和地高辛治疗对住院风险和资源利用风险的影响。
6. Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52) [O] . Sunghwan Suh, Gi Hyeon Seo, Chang Hee Jung, 2015

机译：应对：使用韩国医疗保险理赔数据库的新处方的二肽基肽酶-4抑制剂和吡格列酮增加了因心力衰竭住院的风险（Diabetes Metab J 2015; 39：247-52）
7. Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database ( 2015;39:247-52) [O] . Sunghwan Suh, Gi Hyeon Seo, Chang Hee Jung, 2015

机译：回应：使用韩国健康保险索赔数据库（2015; 39：247-52），使用新规定的二肽基肽酶-4抑制剂和吡格列酮增加心力衰竭住院风险

Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database

摘要

著录项

相似文献

相关主题

期刊订阅